CEACAM5 and adenoma: Similarly, carcinoembryonic antigen (CEA) is a marker approved under limited circumstances to monitor colon cancer recurrence but other markers that might complement CEA performance or serve independently for early detection of adenomas and invasive colon cancer are still only under development [43].